Follicle-stimulating hormone is associated with low bone mass in postmenopausal women

By sjmartinez • January 25, 2023

Mattick LJ, Bea JW, Hovey KM, Wactawski-Wende J, Cauley JA, Crandall CJ, Tian L, Ochs-Balcom HM. Follicle-stimulating hormone is associated with low bone mass in postmenopausal women. Osteoporos Int. 2023 Jan 24. doi: 10.1007/s00198-023-06676-z. Epub ahead of print. PMID: 36692543.

Tags: Bone loss, Estradiol, Follicle stimulating hormone, General Internal Medicine, menopause, Osteoporosis, Publications

Sequencing of anti-CD19 therapies in the management of diffuse large B-cell lymphoma

Lownik J, Boiarsky J, Birhiray R, Merchant A, Mead M. Sequencing of anti-CD19 therapies in the management of diffuse large B-cell lymphoma. Clin Cancer Res.[...]

Outpatient hospitalist-run procedure service bridges the gap in oncology care

Ghanem G, Tsai HHC, Durant C, Feigenbaum GS, Glaeser AM. Outpatient hospitalist-run procedure service bridges the gap in oncology care. Transfus Apher Sci. 2024 Apr[...]

Statewide Survey of Primary Care and Subspecialty Providers on Hepatocellular Carcinoma Risk-Stratification and Surveillance Practices

Moon AM, Swier RM, Lane LM, Barritt AS 4th, Sanoff HK, Olshan AF, Wheeler SB, Ioannou GN, Kim NJ, Hagan S, Vutien P, Benefield T,[...]